Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats

Journal of Neuroscience Research

Volumn 77, Issue 1, 2004, Pages 148-152

  Yan, Yi ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Calcitonin gene related peptide (CGRP); Iontophoretic application; Kappa opioid receptor; Mu opioid receptor; Wide dynamic range neurons

Indexed keywords

BETA FUNALTREXAMINE; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; DELTA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; IMMUNOREACTIVITY; INFLAMMATION; IONTOPHORESIS; NERVE CELL; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL CORD DORSAL HORN;

ACTION POTENTIALS; AFFERENT PATHWAYS; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CELL MEMBRANE; ELECTRIC STIMULATION; MALE; NARCOTIC ANTAGONISTS; NEURAL INHIBITION; NOCICEPTORS; PAIN; PEPTIDE FRAGMENTS; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 3042809788     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20111     Document Type: Article

References (28)

1. Abbadie C, Pasternak GW, Aicher SA. 2001. Presynaptic localization of the carboxyl-terminus epitopes of the μ opioid receptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord. Neuroscience 106:833-842.
2. Ballet S, Mauborgne A, Benoliel JJ, Bourgoin S, Hamon M, Cesselin F, Collin E. 1998. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat. Brain Res 796:198-208.
3. Carlton SM, Westlund KN, Zhang DX, Sorkin LS, Willis WD. 1990. Calcitonin gene-related peptide containing peptide-labeled terminals in the rat lumber dorsal horn. Neurosci Lett 90:27-32.
4. Collin E, Frechilla D, Pohl M, Bourgoin S, Bars DL, Hamon M, Cesselin F. 1993. Opioid control the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Brain Res 609:211-222.
5. Dado RJ, Law PY, Loh HH, Elde R. 1993. Immunofluorescent identification of a delta-opioid receptor on primary afferent nerve terminals. Neuroreport 5:341-344.
6. Dickenson AH, Sullivan AP. 1990. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurons in the rat. Brain Res 506:31-39.
7. Duggan AW, Hendry IA, Morton CR, Hutchinson WD, Zhao ZQ. 1988. Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 451:261-273.
8. Fowler CJ, Fraser GL. 1994. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int 24:401-426.
9. Jiang MC, Cleland CL, Gebhart GF. 1995. Intrinsic properties of deep dorsal horn neurons in the L6-S1 spinal cord of the intact rat. J Neurophysiol 74:1819-1827.
10. Lembeck F, Donnerer J. 1985. Opioid control of the primary afferent substance P fiber. Eur J Pharmacol 114:241-246.
11. Li JL, Ding YQ, Li YQ, Li JS, Nomura S, Kaneko T, Mizuno N. 1998. Immunocytochemical localization of μ-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res 794:347-352.
12. Li N, Lundeberg T, Yu LC. 2001. Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats. Brain Res 901:161-166.
13. Narita M, Funada M, Suzuki T. 2001. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 89:1-15.
14. Pohl M, Lombard MC, Bourgoin S, Benoliel JJ, Mauborgne A, Besson JM, Hamon M, Cesselin F. 1989. Opioid control of the in vitro release of calcitonin gene-related peptide from primary afferent fibers projecting in the rat cervical cord. Neuropeptides 14:151-159.
15. Pohl M, Collin E, Bourgoin S, Clot AM, Hamon M, Cesselin F, Le Bars D. 1992. In vivo release of calcitonin gene-related peptide-like material from the cervicotrigeminal area in the rat. Effects of electrical and noxious stimulation of the muzzle. Neuroscience 50:697-706.
16. Przewlocki R, Przewlocka B. 2001. Opioids in chronic pain. Eur J Pharmacol 429:79-91.
17. Riedel W, Neeck G. 2001. Nociception, pain, and antinociception: current concepts. Z Rheumatol 60:404-415.
18. Sotgiu ML, Biella G. 1998. Contralateral inhibitory control of spinal nociceptive transmission in rats with chronic peripheral nerve injury. Neurosci Lett 253:21-24.
19. van Rossum D, Hanisch UK, Quirion R. 1997. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev 21:649-678.
20. Xu SL, Lundeberg T, Yu LC. 2000. Antinociceptive effects of calcitonin gene-related peptide injected into periaqueductal grey of rats with mononeuropathy. Brain Res 859:358-360.
21. Yaksh TL, Malmberg AB. 1994. Central pharmacology of nociceptive transmission. In: Wall PD, Melzack R, editors. Textbook of rain, 3rd ed. Edinburgh: Churchill Livingston. p 165-190.
22. Ye Z, Wimalawansa SJ, Westlund KN. 1999. Receptor for calcitonin gene-related peptide: localization in the dorsal and ventral spinal cord. Neuroscience 92:1389-1397.
23. Yu LC, Hansson P, Lundeberg T. 1994. The calcitonin gene-related peptide antagonist CGRP8-37 increase the latency to withdrawal response in rats. Brain Res 653:223-230.
24. Yu LC, Hansson P, Lundeberg T. 1995. Opioid antagonist naloxone, β-funaltrexamine and naltrindole, but not nor-binaltorphimine, reverse the increased hindpaw withdrawal latency in rats induced by intrathecal administration of the calcitonin gene-related peptide antagonist CGRP8-37. Brain Res 698:23-29.
25. Yu LC, Hansson P, Lundeberg T. 1996a. The calcitonin gene-related peptide antagonist CGRP8-37 increase the latency to withdrawal responses bilaterally in rats with unilateral experimental mononeuropathy, an effect partly reversed by naloxone. Neuroscience 21:523-531.
26. Yu LC, Hansson P, Brodda-Jansen G, Lundeberg T. 1996b. Intrathecal CGRP8-37 results in a bilateral increase in hindpaw withdrawal latency in rats with experimentally induced unilateral inflammation. Br J Pharmacol 117:43-50.
27. Yu Y, Lundeberg T, Yu LC. 2002. Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats. Regul Pept 103:23-27.
28. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.